The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Paradoxical association of B7H3 with clinical outcomes in patients with colorectal cancer.
 
Yan Huang
No Relationships to Disclose
 
Xiaohua Qi
No Relationships to Disclose
 
Ana Acuna-villaorduna
No Relationships to Disclose
 
Radhika Gali
No Relationships to Disclose
 
Radhashree Maitra
No Relationships to Disclose
 
Juan Lin
No Relationships to Disclose
 
Catarina Maia
No Relationships to Disclose
 
Wei Zhang
No Relationships to Disclose
 
Chenxin Zhang
No Relationships to Disclose
 
Xingxing Zang
No Relationships to Disclose
 
Qiang Liu
No Relationships to Disclose
 
Sanjay Goel
Stock and Other Ownership Interests - Johnson and Johnson; Merck; Moderna Therapeutics
Honoraria - GlaxoSmithKline
Research Funding - Amgen (Inst); BioMed Valley Discoveries (Inst); Deciphera (Inst); Dragonfly Therapeutics (Inst); Eisai (Inst); Exelixis (Inst); Genentech (Inst); Takeda (Inst); Xilio Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - I have a patent with a co-inventor, John Mariadason, Ph.D, entitled "Method Of Determining The Sensitivity Of Cancer Cells To EGFR Inhibitors Including Cetuximab, Panitumumab And Erlotinib.", Patent No. 20090258364